The Department of Health and Human Services (HHS) has funneled at least $2.7 million into a University of Pittsburgh (Pitt) project that utilizes a tissue bank with organs from aborted fetuses, according to a release from Judicial Watch Tuesday.
The conservative nonprofit obtained hundreds of pages of public records requests, which detail Pitt's interest in harvesting fetal organs for a project known as the GenitoUrinary Development Molecular Anatomy Project, or GUDMAP. More money was requested by the university but it's unclear exactly how much it received.
Pitt's application specified that it sought to "develop a pipeline to the acquisition, quality control and distribution of human genitourinary [urinary and genital organs and functions] samples obtained throughout development (6-42 weeks gestation)." Forty-two weeks represents more than 10 months of pregnancy.
In 2015, Pitt told HHS that it has been "collecting fetal tissue for over 10 years includ[ing] liver, heart, gonads, legs, brain, genitourinary tissues including kidneys, ureters and bladders."
It also revealed that the university sought a large number of minority fetuses, according to Judicial Watch something Center for Medical Progress founder David Daleiden described as "racist."
TESTIMONY FROM PLANNED PARENTHOOD, TISSUE PROCURER SHEDS LIGHT ON BABIES BORN ALIVE, WITH BEATING HEARTS
The university told Fox News that the higher number of minorities resulted from an emphasis on those populations most impacted by kidney disease. "Projects funded by the National Institutes of Health must ensure appropriate inclusion of women and minorities," said David Seldin, assistant vice chancellor for news.
"They should also ensure distribution of the study reflects the population needed to accomplish the scientific goals of the study. Asked another way: Does the makeup of the study reflect the populations affected by the illness in question? In the case of the GUDMAP Tissue Hub, one of the goals is to support researchers looking for treatments and cures for kidney disease."
In a PureFlix interview last year, former university employee Lori Kelly discussed a federally funded project with researchers seeking to collect bladders and kidneys from babies as late as 24 weeks into pregnancy. Kelly said that as project manager, she worked to develop "a pull-down menu of baby body parts for researchers to choose from to submit to the tissue bank, so that we could send the body parts to them."
BLACK PRO-LIFE LEADERS PAN PLANNED PARENTHOOD'S SANGER DISAVOWAL: LIKE CHANGING THE NAME OF AUSCHWITZ
"And these researchers were all across the United States," she said,"from Florida to California." When asked, the University of Pittsburgh did not respond to Kelly's allegations earlier this year.
Both the university and its medical center have denied any wrongdoing.
Tuesday's revelation adds mounting scrutiny to a school that has already received attention for its use of fetal tissue.
"The University of Pittsburgh complies with rigorous regulatory and ethical oversight of fetal tissue research," Paul Supowitz, the university's vice chancellor, previously told lawmakers."The researchers in this matter followed all applicable federal and state guidelines and regulations (with Pennsylvania having one of the most restrictive set of requirements in the nation), as well as strict protocols approved by the University. The Universitys Institutional Review Board approved the acquisition of stem cells."
The National Institutes of Health (NIH) has also maintained that it complies with federal law. It previously told Fox News: "NIH is committed to ensuring that research involving human fetal tissue is conducted responsibly and meets the highest ethical standards."
ON THE 48TH ANNIVERSARY OF ROE V. WADE, QUESTIONS REMAIN IN PLANNED PARENTHOOD CONTROVERSIES
Earlier this year, Pennsylvania's state legislature held a hearing in which members discussed an experiment involving grafting fetal scalps, containing "full-thickness human skin," onto rodents.
That particular project utilized tissue from the university's human tissue bank. It was also supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), which is led by top coronavirus adviser Dr. Anthony Fauci. While it's unclear exactly how much federal money was spent on that project, it was funded through two large grants one $1,498,642 and one $430,270.
David Daleiden, the anti-abortion journalist who testified at May's hearing, said on Tuesday: "The NIH grant application for just one of Pitts numerous experiments with aborted infants reads like an episode of American Horror Story People are outraged by such disregard for the lives of the vulnerable. Law enforcement and public officials should act immediately to bring the next Kermit Gosnell to justice under the law."
The documents uncovered by Judicial Watch also show Pitt discussing its effort to minimize warm ischemic time, or the amount of time an organ maintains its body temperature after blood flow has been severed. It's unclear how these procedures take place, but Daleiden has raised concerns about the university's stated use of labor induction abortions.
ELIZABETH WARREN: ABORTION IS ABOUT THE FUNCTIONING OF OUR DEMOCRACY
"If the fetus heartbeat and blood circulation continue in a labor induction abortion for harvesting organs, it means the fetus is being delivered while still alive and the cause of death is the removal of the organs," reads a press release from his Center for Medical Progress. Typically, abortion procedures rely on digoxin to kill a fetus. However, both that and dismemberment tactics can ruin viable tissue intended for donations.
In a statement to Fox News, Seldin said clarified the researchers have "no part in any decisions as to timing, method, or procedures used to terminate the pregnancy."
Ischemia time, he said "refers to the time after the tissue collection procedure and before cooling for storage and transport. It does not have an impact on how the procedure is performed, which is always at the discretion of the attending physician and determined with the patients health as the top priority."
Seldin added that all tissue was obtained in compliance with the Pennsylvania Abortion Control Act, which lays out a series of regulations for performing the procedure. It also contains a section banning infanticide, noting that: "The law of this Commonwealth shall not be construed to imply that any human being born alive in the course of or as a result of an abortion or pregnancy termination, no matter what may be that human being's chance of survival, is not a person under the Constitution and laws of this Commonwealth."
In May, the university provided Fox News with a statement defending the use of fetal tissue research.
CLICK HERE TO GET THE FOX NEWS APP
"Researchers at Pitt and other leading medical research institutions use fetal tissue in certain instances because it has proven to be an important method for combatting and curing some of our most devastating diseases, including ALS, Parkinsons disease, Alzheimers disease, spinal cord injury and others," read the statement.
On Wednesday, Seldin added that "[t]his grant supported research to find new therapies for diseases of the kidneys, bladder and urinary systems, which are a leading cause of organ failure. By providing a central hub for researchers across the country, this program allowed scientists across the country to access tissue necessary to tackle this growing public health concern."
See the original post:
Millions in federal money flowed to tissue bank that collected fetal 'heart, gonads, legs, brain': report - Fox News
- Kyle Orwig received the Distinguished Researcher Award from the American Society for Reproductive Medicine - University of Pittsburgh - October 4th, 2022
- I Have Cancer And I'm Thankful For The Life Science Industry - Clinical Leader - July 19th, 2022
- Whitmer to veto adoption, abortion alternative funds from Michigan budget - Bridge Michigan - July 19th, 2022
- Tevogen Bio Appoints Acclaimed Oncologist and Immunotherapy Expert Neal Flomenberg, M.D. as Chief Scientific Officer and Global Head of R&D - Yahoo... - July 11th, 2022
- Amendment added to PA budget bill would make Pitt, other universities stop fetal tissue research - WPXI Pittsburgh - July 3rd, 2022
- Free Fecal Water Syndrome in Horses and What To Do About It The Horse - TheHorse.com - July 3rd, 2022
- PAWcast: Valedictorian Natalia Orlovsky '22 on Research, Mental Health, and Pandemic Princeton - Princeton Alumni Weekly - July 3rd, 2022
- Opinion | Pro-Life Representatives may be the reason thousands of students cant afford Pitt - The Pitt News - June 22nd, 2022
- Tackling chronic disease with gene and cell therapies - The Irish Times - May 2nd, 2022
- How one inflammatory disorder exacerbates another | Penn Today - Penn Today - May 2nd, 2022
- ChristianaCare and The Wistar Institute Advance Partnership With New Cancer Research Strategies - ChristianaCare News - March 25th, 2022
- The Incredible Story of Emily Whitehead & CAR T-Cell Therapy : Oncology Times - LWW Journals - March 25th, 2022
- Penn State recipients of Whitaker Center's Women of Impact 2021 awards unite through research - The Daily Collegian Online - March 25th, 2022
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Stockhouse - October 28th, 2021
- NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - National Institutes of Health - October 28th, 2021
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases - FDA.gov - October 28th, 2021
- People and places at Penn | Penn Today - Penn Today - Penn Today - August 18th, 2021
- Bispecific Antibodies Wage a Two-Pronged Attack on Tumors - Curetoday.com - June 23rd, 2021
- Newly Discovered Glycosylated RNA Is All Over Cells: Study - The Scientist - May 25th, 2021
- Penn researchers find a way through the labyrinth keeping CAR-T from solid tumors - Endpoints News - December 7th, 2020
- 'Benjamin Button' discovery could reverse ageing process - Queensland Times - December 7th, 2020
- The story of mRNA: From a loose idea to a tool that may help curb Covid - STAT - November 11th, 2020
- Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care - Sky Hi News - September 12th, 2020
- T cells, B cells and the range of the human bodys immune response A simple decoder - ThePrint - August 10th, 2020
- Are very long-lived trees immortal and what can they teach humans? - ABC News - August 10th, 2020
- Eradicating balding a step closer with new procedure in the cross hairs - The New Daily - June 4th, 2020
- Coming Together to Solve COVID-19 Mysteries | University of Pennsylvania Almanac - UPENN Almanac - June 4th, 2020
- Orthopedics - Pennsylvania Stem Cell Center - May 25th, 2020
- Stem Cell Treatment Bala Cynwyd | Stem Cell Therapy ... - May 25th, 2020
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Board - BioSpace - May 11th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 11th, 2020
- Pregnant and positive | Scientists look for COVID-19 immunity in the womb - WHAS11.com - April 23rd, 2020
- Why Choose Us - Pennsylvania Stem Cell Center - April 10th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 10th, 2020
- The potential use of CRISPR to treat disease is gaining momentum - BioNews - January 16th, 2020
- What a time to be alive: Reproductive breakthroughs of the 2010s that changed life as we know it - FOX 10 News Phoenix - January 3rd, 2020
- 2019: The year gene therapy came of age - Jamaica Observer - December 9th, 2019
- Trevena Inc. (TRVN)'s Financial Results Comparing With VistaGen Therapeutics Inc. (NASDAQ:VTGN) - The Broch Herald - December 9th, 2019
- 253 miles in 4 hours: A Syracuse mans race for a lung transplant, and the angel who helped him - syracuse.com - December 1st, 2019
- Head to Head Survey: BioRestorative Therapies (OTCMKTS:BRTX) & Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - December 1st, 2019
- Critical Review: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - NCTY News - November 16th, 2019
- These Israeli Companies Are Finding Innovative Ways To Improve Diabetes Care, Treatment | Health News - NoCamels - Israeli Innovation News - November 16th, 2019
- Reviewing BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - November 16th, 2019
- Reviewing Madrigal Pharmaceuticals Inc. (MDGL)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 30th, 2019
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 30th, 2019
- AI uncovers genes linked to heart failure - FierceBiotech - September 27th, 2019
- University of Pennsylvania || Cell and Molecular Biology ... - September 7th, 2019
- Robert Lanza - Wikipedia - May 12th, 2019
- Cary Ortho Utilizes Bone Marrow Stem Cells for General ... - May 12th, 2019
- Stem Cell Therapy in Lancaster Pennsylvania | Stem Cell ... - April 24th, 2019
- Lung Institute Review | Do Stem Cell Treatments Work? - April 21st, 2019
- Cells Weekly October 11, 2015 - stemcellassays.com - February 5th, 2019
- Pittsburgh, Pennsylvania - Stem Cells Transplant Institute - November 18th, 2018
- Stem Cell Therapy in York County, Pennsylvania - October 8th, 2018
- Regrowing dental tissue with stem cells from baby teeth ... - October 2nd, 2018
- About Penn's IRM - Institute for Regenerative Medicine - September 16th, 2018
- Stem Cell Treatment - Philadelphia Bala Cynwyd, PA: World ... - August 13th, 2018
- Stem Cell Therapy in Conewago Township, Pennsylvania - July 19th, 2018
- Meetings - October 8th, 2017
- Tucson's Calimmune to be acquired by Australian drug giant - Arizona Daily Star - August 30th, 2017
- Hair Regrowth using Stem Cells | Ashley and Martin - August 30th, 2017
- Bone Marrow Protein May Be Target for Improving Stem Cell Transplants - Penn: Office of University Communications - August 30th, 2017
- Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young ... - GlobeNewswire (press release) - August 30th, 2017
- COLUMN: Startling statistics concerning drug deaths in rural communities - Meadville Tribune - August 25th, 2017
- Rare leukemia targeted by modifying patients' immune cells - New Haven Register - August 7th, 2017
- Campus achievement - Sunbury Daily Item - August 7th, 2017
- La Jolla Light News Nuggets: July 27 - La Jolla Light - July 30th, 2017
- 2016 Scientific Program - December 4th, 2016
- Tissue Niches & Resident Stem Cells in Adult Epithelia - GRC - August 26th, 2016
- Knee Stem Cell Therapy and Platelet Procedures Pittsburgh ... - July 2nd, 2015
- Penn vet team points to new colon cancer culprit - March 16th, 2015
- MD Anderson Names Hwu as Head of Cancer Medicine - February 26th, 2015
- Stemiotics Licenses Modified RNA for Cell Reprogramming - December 22nd, 2014
- Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019 - December 8th, 2014
- Cyanide killed hospital employee, official says - November 29th, 2014
- An Eclectic Path to Precision Medicine - November 25th, 2014
- First Study to Convert Adult Human Cells to Hair-Follicle ... - November 2nd, 2014
- Stem Cell and Xenograft Core: Biomedical Research Core ... - October 27th, 2014
- Immune Therapy Induces Remission for Many With a Tough-to-Treat Blood Cancer - October 18th, 2014
- Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014 - October 16th, 2014